Location:


Online Cost:
At Door Cost:

Speaker(s):
Dr. John Clarkson, Compensation Committee Chairman, Noven Pharmaceuticals. Dr. Clarkson is also the Executive Director of the American Board of Ophthalmology and the Dean Emeritus and professor of ophthalmology, Miller School of Medicine at the University of Miami. Dr. Clarkson also serves on the board of governors of the UMHC/Sylvester Cancer Center and Anne Bates Leach Eye Hospital and on the board of directors of the Jackson Memorial Hospital/Public Health Trust.

Joe Lacher, Compensation Committee Chairman, Goodwill Industries.

Mr. Lacher also currently serves as chairman of Great Florida Bank (largest and fastest growing DeNovo bank in the United States), is a board member of TECO Energy, Inc., a board member, audit committee chairman and compensation committee chairman of Perry Ellis International, and a director for Goodwill Industries of South Florida.

Danielle Price, Attorney, Holland & Knight, practices in the areas of corporate law, securities, mergers and acquisitions, venture capital, and corporate governance.

Evelyn D’An, President and Founder of D’An Financial Services. DFS provides the expertise and insight of highly qualified accounting, finance, information technology, and strategic tax professionals to clients. Evelyn currently serves on the board of directors and the audit committee of Alico, Inc., a Nasdaq registered public company, based in Florida. She also serves on the audit committee for the City of Miami.

Details:
Dr. Clarkson and Joe Lacher shared their views on the new compensation disclosure rules, from both an SEC and a not-for-profit perspective, while Danielle Price addressed the legal compliance requirements. Evelyn D’An, moderated the discussion and addressed the question – “What Does It All Mean?” The reporting requirements of the new compensation disclosures and the impact to companies and to the shareholders were addressed.